Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED.

Pain. 2012 Apr;153(4):744-54. doi: 10.1016/j.pain.2012.01.002. Epub 2012 Mar 3. Review.

2.

Preclinical research on pain comorbidity with affective disorders and cognitive deficits: Challenges and perspectives.

Liu MG, Chen J.

Prog Neurobiol. 2014 May;116:13-32. doi: 10.1016/j.pneurobio.2014.01.003. Epub 2014 Jan 18. Review.

PMID:
24444673
3.

Forebrain pain mechanisms.

Neugebauer V, Galhardo V, Maione S, Mackey SC.

Brain Res Rev. 2009 Apr;60(1):226-42. doi: 10.1016/j.brainresrev.2008.12.014. Epub 2008 Dec 31. Review.

4.

In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

Nikolaus S, Antke C, Müller HW.

Behav Brain Res. 2009 Dec 1;204(1):32-66. doi: 10.1016/j.bbr.2009.06.009. Epub 2009 Jun 10. Review.

PMID:
19523495
5.

Cerebral stimulation for the affective component of neuropathic pain.

Machado AG, Baker KB, Plow E, Malone DA.

Neuromodulation. 2013 Nov-Dec;16(6):514-8. doi: 10.1111/j.1525-1403.2012.00517.x. Epub 2012 Oct 24. Review.

6.

[Dopaminergic modulation of cerebral activity and cognitive functions].

Jucaite A.

Medicina (Kaunas). 2002;38(4):357-62. Review. Lithuanian.

7.

[Neurocognition of psychiatric patients].

Brand M, Markowitsch HJ.

Psychiatr Prax. 2004 Nov;31 Suppl 2:S200-9. German.

PMID:
15586311
8.

Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation.

Sarter M, Bruno JP, Parikh V.

Neuropsychopharmacology. 2007 Jul;32(7):1452-61. Epub 2006 Dec 13. Review.

9.

The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.

Goto Y, Grace AA.

Int Rev Neurobiol. 2007;78:41-68. Review.

PMID:
17349857
10.
11.

Dopamine and the diseased brain.

Kienast T, Heinz A.

CNS Neurol Disord Drug Targets. 2006 Feb;5(1):109-31. Review.

PMID:
16613557
12.

A dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey.

Oikonomidis L, Santangelo AM, Shiba Y, Clarke FH, Robbins TW, Roberts AC.

Dev Neurobiol. 2017 Mar;77(3):328-353. doi: 10.1002/dneu.22446. Review.

13.

Dopamine precursor depletion influences pain affect rather than pain sensation.

Tiemann L, Heitmann H, Schulz E, Baumkötter J, Ploner M.

PLoS One. 2014 Apr 23;9(4):e96167. doi: 10.1371/journal.pone.0096167. eCollection 2014.

14.

Studies of altered social cognition in neuropsychiatric disorders using functional neuroimaging.

Grady CL, Keightley ML.

Can J Psychiatry. 2002 May;47(4):327-36. Review.

PMID:
12025431
15.

Neurobiology of dopamine in schizophrenia.

Guillin O, Abi-Dargham A, Laruelle M.

Int Rev Neurobiol. 2007;78:1-39. Review.

PMID:
17349856
16.

Role of central dopamine in pain and analgesia.

Wood PB.

Expert Rev Neurother. 2008 May;8(5):781-97. doi: 10.1586/14737175.8.5.781. Review.

PMID:
18457535
17.

Modeling psychotic and cognitive symptoms of affective disorders: Disrupted latent inhibition and reversal learning deficits in highly stress reactive mice.

Knapman A, Heinzmann JM, Holsboer F, Landgraf R, Touma C.

Neurobiol Learn Mem. 2010 Sep;94(2):145-52. doi: 10.1016/j.nlm.2010.04.010. Epub 2010 May 6.

PMID:
20451634
18.
19.

Neurological and physiological bases of psychopathology.

Reitan RM.

Annu Rev Psychol. 1976;27:189-216. Review. No abstract available.

PMID:
773261

Supplemental Content

Support Center